Nitrofurantoin Sustained Release Tablets 100MG - ENFURIN SR Tablets

ENFURIN SR Tablets – Targeted Antibacterial Action for Urinary Tract Infections.

ENFURIN SR Tablets – Nitrofurantoin Sustained Release Tablets 100MG is a sustained-release formulation of Nitrofurantoin, a potent urinary antiseptic and bactericidal agent that works by disrupting bacterial DNA, RNA, and protein synthesis. The SR technology ensures steady drug levels in the bloodstream, enabling twice-daily dosing and improved patient compliance.
It demonstrates high efficacy against prevalent uropathogens such as E. coli, Enterococcus, and Klebsiella species, making it a reliable option in UTI management.

Key Benefits of Torsemide & Spironolactone Tablets – DYLIX PLUS 20/50 Tablets
✅Sustained-Release for Extended Protection: Ensures continuous urinary antibacterial activity through controlled drug release, minimizing dosing frequency and improving adherence.
✅ Targeted action: Torsemide acts explicitly on the urinary tract, allowing targeted pathogen elimination without significant systemic side effects or impact on gut flora.
✅Effective in Preventing Recurrences: Well-suited for long-term use in patients prone to recurrent or uncomplicated UTIs, with a favorable safety and tolerability profile.

Recommended by Specialists:
👨‍⚕️Urologists – For both treatment and prevention of uncomplicated lower UTIs, particularly in female patients.
👨‍⚕️General Physicians – Widely prescribed for acute cystitis and as a prophylactic agent against recurrent UTIs.
👨‍⚕️Gynecologists – frequently recommend treatment in cases of chronic or recurring UTIs in women.
👨‍⚕️Nephrologists – Used as first-line treatment for managing lower urinary tract infections in patients with appropriate renal function.

Indications:
✅Acute uncomplicated urinary tract infections (UTIs)
✅Prophylaxis of recurrent UTIs
✅Cystitis
✅Prevention of post-operative UTIs
✅Lower urinary tract infections